Oestradiol signalling through the Akt-mTORC1-S6K1

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 5, 2013, Pages 1052-1064

  Varea, O ^a,b   Escoll, M ^a,b   Diez, H ^a,b   Garrido, J J ^a,b,c   Wandosell, F ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c INSTITUTO CAJAL   (Spain)

Author keywords

Estradiol cytoplasmic signalling; Estrogen; Rheb activation; S6 kinase activation

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RHEB PROTEIN; S6 KINASE;

ANIMAL CELL; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; EMBRYO; MORPHOGENESIS; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CELL LINE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; MICE; MULTIPROTEIN COMPLEXES; NEUROBLASTOMA; NEURONS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84874547373     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.12.019     Document Type: Article

References (73)

1. Nishio M., Kuroki Y., Watanabe Y. Subcellular localization of estrogen receptor beta in mouse hippocampus. Neurosci. Lett. 2004, 355:109-112.
2. Milner T.A., Ayoola K., Drake C.T., Herrick S.P., Tabori N.E., McEwen B.S., Warrier S., Alves S.E. Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J. Comp. Neurol. 2005, 491:81-95.
3. Xu Y., Traystman R.J., Hurn P.D., Wang M.M. Neurite-localized estrogen receptor-alpha mediates rapid signaling by estrogen. J. Neurosci. Res. 2003, 74:1-11.
4. Gould E., Woolley C.S., Frankfurt M., McEwen B.S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J. Neurosci. 1990, 10:1286-1291.
5. Woolley C.S., McEwen B.S. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Neurosci. 1992, 12:2549-2554.
6. Kelly M.J., Ronnekleiv O.K. Control of CNS neuronal excitability by estrogens via membrane-initiated signaling. Mol. Cell. Endocrinol. 2009, 308:17-25.
7. von Schassen C., Fester L., Prange-Kiel J., Lohse C., Huber C., Bottner M., Rune G.M. Oestrogen synthesis in the hippocampus: role in axon outgrowth. J. Neuroendocrinol. 2006, 18:847-856.
8. Vivar O.I., Zhao X., Saunier E.F., Griffin C., Mayba O.S., Tagliaferri M., Cohen I., Speed T.P., Leitman D.C. Estrogen receptor beta binds to and regulates three distinct classes of target genes. J. Biol. Chem. 2010, 285:22059-22066.
9. Cardona-Gomez G.P., Mendez P., Garcia-Segura L.M. Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus. Brain Res. Mol. Brain Res. 2002, 107:80-88.
10. Cardona-Gomez P., Perez M., Avila J., Garcia-Segura L.M., Wandosell F. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol. Cell. Neurosci. 2004, 25:363-373.
11. Jiang H., Guo W., Liang X., Rao Y. Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators. Cell 2005, 120:123-135.
12. Inoki K., Li Y., Zhu T., Wu J., Guan K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 2002, 4:648-657.
13. Manning B.D., Tee A.R., Logsdon M.N., Blenis J., Cantley L.C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 2002, 10:151-162.
14. Codeluppi S., Svensson C.I., Hefferan M.P., Valencia F., Silldorff M.D., Oshiro M., Marsala M., Pasquale E.B. The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord. J. Neurosci. 2009, 29:1093-1104.
15. Kaech S., Banker G. Culturing hippocampal neurons. Nat. Protoc. 2006, 1:2406-2415.
16. Simon D., Benitez M.J., Gimenez-Cassina A., Garrido J.J., Bhat R.V., Diaz-Nido J., Wandosell F. Pharmacological inhibition of GSK-3 is not strictly correlated with a decrease in tyrosine phosphorylation of residues 216/279. J. Neurosci. Res. 2008, 86:668-674.
17. Del'guidice T., Beaulieu J.M. Messing up with traffic: different effects of antipsychotic agents on glutamate receptor complexes in vivo. Mol. Pharmacol. 2008, 73:1339-1342.
18. Schalm S.S., Blenis J. Identification of a conserved motif required for mTOR signaling. Curr. Biol. 2002, 12:632-639.
19. Gensel J.C., Schonberg D.L., Alexander J.K., McTigue D.M., Popovich P.G. Semi-automated Sholl analysis for quantifying changes in growth and differentiation of neurons and glia. J. Neurosci. Methods 2010, 190:71-79.
20. Cambiasso M.J., Carrer H.F. Nongenomic mechanism mediates estradiol stimulation of axon growth in male rat hypothalamic neurons in vitro. J. Neurosci. Res. 2001, 66:475-481.
21. Ferreira A., Caceres A. Estrogen-enhanced neurite growth: evidence for a selective induction of Tau and stable microtubules. J. Neurosci. 1991, 11:392-400.
22. Merot Y., Ferriere F., Debroas E., Flouriot G., Duval D., Saligaut C. Estrogen receptor alpha mediates neuronal differentiation and neuroprotection in PC12 cells: critical role of the A/B domain of the receptor. J. Mol. Endocrinol. 2005, 35:257-267.
23. Rozovsky I., Wei M., Stone D.J., Zanjani H., Anderson C.P., Morgan T.E., Finch C.E. Estradiol (E2) enhances neurite outgrowth by repressing glial fibrillary acidic protein expression and reorganizing laminin. Endocrinology 2002, 143:636-646.
24. Audesirk T., Cabell L., Kern M., Audesirk G. Beta-estradiol influences differentiation of hippocampal neurons in vitro through an estrogen receptor-mediated process. Neuroscience 2003, 121:927-934.
25. Hao J., Rapp P.R., Leffler A.E., Leffler S.R., Janssen W.G., Lou W., McKay H., Roberts J.A., Wearne S.L., Hof P.R., Morrison J.H. Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys. J. Neurosci. 2006, 26:2571-2578.
26. Liu F., Day M., Muniz L.C., Bitran D., Arias R., Revilla-Sanchez R., Grauer S., Zhang G., Kelley C., Pulito V., Sung A., Mervis R.F., Navarra R., Hirst W.D., Reinhart P.H., Marquis K.L., Moss S.J., Pangalos M.N., Brandon N.J. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat. Neurosci. 2008, 11:334-343.
27. Lu H., Nishi M., Matsuda K., Kawata M. Estrogen reduces the neurite growth of serotonergic cells expressing estrogen receptors. Neurosci. Res. 2004, 50:23-28.
28. Mendez P., Azcoitia I., Garcia-Segura L.M. Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Res. Mol. Brain Res. 2003, 112:170-176.
29. Read D.E., Gorman A.M. Involvement of Akt in neurite outgrowth. Cell. Mol. Life Sci. 2009, 66:2975-2984.
30. Varea O., Garrido J.J., Dopazo A., Mendez P., Garcia-Segura L.M., Wandosell F. Estradiol activates beta-catenin dependent transcription in neurons. PLoS One 2009, 4:e5153.
31. Menager C., Arimura N., Fukata Y., Kaibuchi K. PIP3 is involved in neuronal polarization and axon formation. J. Neurochem. 2004, 89:109-118.
32. Polakis P. Casein kinase 1: a Wnt'er of disconnect. Curr. Biol. 2002, 12:R499-R501.
33. Yu X., Malenka R.C. Multiple functions for the cadherin/catenin complex during neuronal development. Neuropharmacology 2004, 47:779-786.
34. Yan D., Wiesmann M., Rohan M., Chan V., Jefferson A.B., Guo L., Sakamoto D., Caothien R.H., Fuller J.H., Reinhard C., Garcia P.D., Randazzo F.M., Escobedo J., Fantl W.J., Williams L.T. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta-catenin signaling is activated in human colon tumors. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:14973-14978.
35. Lustig B., Jerchow B., Sachs M., Weiler S., Pietsch T., Karsten U., van de Wetering M., Clevers H., Schlag P.M., Birchmeier W., Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 2002, 22:1184-1193.
36. Jho E.H., Zhang T., Domon C., Joo C.K., Freund J.N., Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 2002, 22:1172-1183.
37. Morita T., Sobue K. Specification of neuronal polarity regulated by local translation of CRMP2 and Tau via the mTOR-p70S6K pathway. J. Biol. Chem. 2009, 284:27734-27745.
38. Knox S., Ge H., Dimitroff B.D., Ren Y., Howe K.A., Arsham A.M., Easterday M.C., Neufeld T.P., O'Connor M.B., Selleck S.B. Mechanisms of TSC-mediated control of synapse assembly and axon guidance. PLoS One 2007, 2:e375.
39. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., Tempst P., Sabatini D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
40. Jiang H., Vogt P.K. Constitutively active Rheb induces oncogenic transformation. Oncogene 2008, 27:5729-5740.
41. Long X., Lin Y., Ortiz-Vega S., Yonezawa K., Avruch J. Rheb binds and regulates the mTOR kinase. Curr. Biol. 2005, 15:702-713.
42. Hanrahan J., Blenis J. Rheb activation of mTOR and S6K1 signaling. Methods Enzymol. 2006, 407:542-555.
43. Noel S.D., Keen K.L., Baumann D.I., Filardo E.J., Terasawa E. Involvement of G protein-coupled receptor 30 (GPR30) in rapid action of estrogen in primate LHRH neurons. Mol. Endocrinol. 2009, 23:349-359.
44. Brailoiu E., Dun S.L., Brailoiu G.C., Mizuo K., Sklar L.A., Oprea T.I., Prossnitz E.R., Dun N.J. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J. Endocrinol. 2007, 193:311-321.
45. Fan X., Xu H., Warner M., Gustafsson J.A. ERbeta in CNS: new roles in development and function. Prog. Brain Res. 2010, 181:233-250.
46. Merot Y., Ferriere F., Gailhouste L., Huet G., Percevault F., Saligaut C., Flouriot G. Different outcomes of unliganded and liganded estrogen receptor-alpha on neurite outgrowth in PC12 cells. Endocrinology 2009, 150:200-211.
47. Mendez P., Azcoitia I., Garcia-Segura L.M. Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analysing neuroprotective mechanisms. J. Endocrinol. 2005, 185:11-17.
48. Song R.X., Zhang Z., Chen Y., Bao Y., Santen R.J. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology 2007, 148:4091-4101.
49. Mendoza R.A., Enriquez M.I., Mejia S.M., Moody E.E., Thordarson G. Interactions between IGF-I, estrogen receptor-alpha (ERalpha), and ERbeta in regulating growth/apoptosis of MCF-7 human breast cancer cells. J. Endocrinol. 2010, 208:1-9.
50. Delcommenne M., Tan C., Gray V., Rue L., Woodgett J., Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:11211-11216.
51. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., de Falco A., Lombardi M., Fiorentino R., Varricchio L., Barone M.V., Auricchio F. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 2001, 20:6050-6059.
52. Moon R.T., Bowerman B., Boutros M., Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science 2002, 296:1644-1646.
53. Votin V., Nelson W.J., Barth A.I. Neurite outgrowth involves adenomatous polyposis coli protein and beta-catenin. J. Cell Sci. 2005, 118:5699-5708.
54. Peng Y.R., He S., Marie H., Zeng S.Y., Ma J., Tan Z.J., Lee S.Y., Malenka R.C., Yu X. Coordinated changes in dendritic arborization and synaptic strength during neural circuit development. Neuron 2009, 61:71-84.
55. Grider M.H., Park D., Spencer D.M., Shine H.D. Lipid raft-targeted Akt promotes axonal branching and growth cone expansion via mTOR and Rac1, respectively. J. Neurosci. Res. 2009, 87:3033-3042.
56. Park K.K., Liu K., Hu Y., Smith P.D., Wang C., Cai B., Xu B., Connolly L., Kramvis I., Sahin M., He Z. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008, 322:963-966.
57. Yu J., Henske E.P. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain. Cancer Res. 2006, 66:9461-9466.
58. Sun Y., Fang Y., Yoon M.S., Zhang C., Roccio M., Zwartkruis F.J., Armstrong M., Brown H.A., Chen J. Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:8286-8291.
59. Cai D., Zhong M., Wang R., Netzer W.J., Shields D., Zheng H., Sisodia S.S., Foster D.A., Gorelick F.S., Xu H., Greengard P. Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1936-1940.
60. Yoon M.S., Cho C.H., Lee K.S., Han J.S. Binding of Cdc42 to phospholipase D1 is important in neurite outgrowth of neural stem cells. Biochem. Biophys. Res. Commun. 2006, 347:594-600.
61. Yoon M.S., Yon C., Park S.Y., Oh D.Y., Han A.H., Kim D.S., Han J.S. Role of phospholipase D1 in neurite outgrowth of neural stem cells. Biochem. Biophys. Res. Commun. 2005, 329:804-811.
62. Meikle L., Pollizzi K., Egnor A., Kramvis I., Lane H., Sahin M., Kwiatkowski D.J. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J. Neurosci. 2008, 28:5422-5432.
63. Fenton T.R., Gout I.T. Functions and regulation of the 70kDa ribosomal S6 kinases. Int. J. Biochem. Cell Biol. 2010, 43:47-59.
64. Takei N., Inamura N., Kawamura M., Namba H., Hara K., Yonezawa K., Nawa H. Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J. Neurosci. 2004, 24:9760-9769.
65. Freedman R., Olincy A., Buchanan R.W., Harris J.G., Gold J.M., Johnson L., Allensworth D., Guzman-Bonilla A., Clement B., Ball M.P., Kutnick J., Pender V., Martin L.F., Stevens K.E., Wagner B.D., Zerbe G.O., Soti F., Kem W.R. Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am. J. Psychiatry 2008, 165(8):1040-1047.
66. Yamnik R.L., Digilova A., Davis D.C., Brodt Z.N., Murphy C.J., Holz M.K. S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation. J. Biol. Chem. 2009, 284:6361-6369.
67. Ikeuchi Y., Stegmuller J., Netherton S., Huynh M.A., Masu M., Frank D., Bonni S., Bonni A. A SnoN-Ccd1 pathway promotes axonal morphogenesis in the mammalian brain. J. Neurosci. 2009, 29:4312-4321.
68. Sanchez A.M., Flamini M.I., Fu X.D., Mannella P., Giretti M.S., Goglia L., Genazzani A.R., Simoncini T. Rapid signaling of estrogen to WAVE1 and moesin controls neuronal spine formation via the actin cytoskeleton. Mol. Endocrinol. 2009, 23:1193-1202.
69. Bradke F., Dotti C.G. The role of local actin instability in axon formation. Science 1999, 283:1931-1934.
70. Da Silva J.S., Medina M., Zuliani C., Di Nardo A., Witke W., Dotti C.G. RhoA/ROCK regulation of neuritogenesis via profilin IIa-mediated control of actin stability. J. Cell Biol. 2003, 162:1267-1279.
71. Sanchez A.M., Simoncini T. Extra-nuclear signaling of ERalpha to the actin cytoskeleton in the central nervous system. Steroids 2010, 75:528-532.
72. Sanchez A.M., Flamini M.I., Baldacci C., Goglia L., Genazzani A.R., Simoncini T. Estrogen receptor-{alpha} promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP. Mol. Endocrinol. 2010, 24:2114-2125.
73. Sarkar S.N., Smith L.T., Logan S.M., Simpkins J.W. Estrogen-induced activation of extracellular signal-regulated kinase signaling triggers dendritic resident mRNA translation. Neuroscience 2010, 170:1080-1085.